11:19:35 EDT Mon 14 Oct 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
GeneNews Ltd (2)
Symbol C : GEN
Shares Issued 143,588,177
Close 2018-11-13 C$ 0.045
Recent Sedar Documents

GeneNews to release Q3 results Nov. 15

2018-11-13 17:37 ET - News Release

Mr. James Howard-Tripp reports

GENENEWS ANNOUNCES THIRD QUARTER 2018 RESULTS INVESTOR CALL

GeneNews Ltd. will release its third quarter 2018 financial results before markets open on Thursday, Nov. 15, 2018. GeneNews chairman and chief executive officer James R. Howard-Tripp will host a conference call at 8:30 a.m. ET on Nov. 15, 2018, to review the financial results and discuss business developments for the period. He will also present the new investor presentation and website.

Third quarter 2018 results conference call details

Date:  Thursday, Nov. 15, 2018

Time:  8:30 a.m. EST

Live call

Local -- Toronto:  1-416-764-8609

Toll-free -- North America:  1-888-390-0605

Conference ID No.:  40595231

Playback phone numbers

Local -- Toronto:  1-416-764-8677

Toll-free -- North America:  1-888-390-0541

Playback passcode:  595231 followed by the pound key

Playback expiration date:  Thursday, Nov. 22, 2018, 11:59 p.m.

The call will also be broadcast live and archived on the company's website in the investors section.

About GeneNews Ltd.

GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Its mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.